Abeona Therapeutics, Inc. (ABEO)
5.85
-0.07
(-1.18%)
USD |
NASDAQ |
Aug 31, 16:00
5.86
+0.01
(+0.17%)
After-Hours: 20:00
Abeona Therapeutics Total Long Term Debt (Quarterly) : 18.59M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.59M |
| March 31, 2026 | 21.90M |
| December 31, 2025 | 24.10M |
| September 30, 2025 | 24.00M |
| June 30, 2025 | 23.54M |
| March 31, 2025 | 23.36M |
| December 31, 2024 | 22.22M |
| September 30, 2024 | 22.05M |
| June 30, 2024 | 21.37M |
| March 31, 2024 | 22.12M |
| December 31, 2023 | 4.402M |
| September 30, 2023 | 4.043M |
| June 30, 2023 | 4.377M |
| March 31, 2023 | 5.53M |
| December 31, 2022 | 5.854M |
| September 30, 2022 | 6.484M |
| June 30, 2022 | 6.737M |
| March 31, 2022 | 7.273M |
| December 31, 2021 | 7.56M |
| September 30, 2021 | 4.442M |
| June 30, 2021 | 6.48M |
| March 31, 2021 | 6.752M |
| December 31, 2020 | 7.018M |
| September 30, 2020 | 5.517M |
| June 30, 2020 | 5.768M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.013M |
| December 31, 2019 | 6.251M |
| September 30, 2019 | 6.482M |
| June 30, 2019 | 6.708M |
| March 31, 2019 | 6.927M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Forum Markets, Inc. | 25.95M |
| Corcept Therapeutics, Inc. | 7.504M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |